Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Nat Cell Biol. 2010 Feb 21;12(3):247–256. doi: 10.1038/ncb2024

Figure 6. miR-9 levels correlate with MYCN amplification and metastatic status in human cancers.

Figure 6

(a) Expression of mature miR-9 in MYCN-normal copy (n = 22) and MYCN-amplified (n = 23) neuroblastoma tumor samples.

(b) Expression of mature miR-9 in primary breast tumor samples from metastasis-free and metastasis-positive patients. Data in a and b are presented as mean ± s.e.m.

(c) Model for miR-9-mediated pathway in cancer metastasis.